| First Author | Pirruccello SJ | Year | 1992 |
| Journal | Am J Pathol | Volume | 140 |
| Issue | 5 | Pages | 1187-94 |
| PubMed ID | 1580330 | Mgi Jnum | J:975 |
| Mgi Id | MGI:49507 | Citation | Pirruccello SJ, et al. (1992) Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease model. Am J Pathol 140(5):1187-94 |
| abstractText | In the course of evaluating the severe combined immunodeficiency mouse-human peripheral blood lymphocyte (SCID-PBL) model of lymphoproliferative disease, we noted hemagglutination occurring in peripheral blood smears of mice with serum human immunoglobulin levels greater than 1.0 mg/ml. The hemagglutinating process was mediated by human anti-mouse red cell antibodies of the IgM class, peaked at five to seven weeks post-transfer of 5 to 7 x 10(7) human PBL and was generally self limiting. However, death resulted in some mice when serum immunoglobulin levels were greater than 3.0 mg/ml. The most severely affected mice had hemagglutination induced congestion of liver, lungs and spleen. Several mice also had lesions consistent with graft-versus-host disease (GVHD) including focal hepatic necrosis and destruction of mouse splenic hematopoietic elements. The lesions associated with hemagglutination and GVHD in SCID-PBL mice are distinct from those associated with EBV-induced lymphoproliferation. Recognition of these pathologic processes are required for a thorough understanding of the SCID-PBL model. |
